Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
17.03
+0.60 (3.63%)
Jun 8, 2026, 10:48 AM EDT - Market open

Odyssey Therapeutics Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Odyssey Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $32. The average 1-year stock price forecast is 87.94% higher than the current stock price, while the lowest is $26 (+52.70%) and the highest is $40 (+134.92%).

Price Target: $32 (+87.94%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$26$32$30$40
Change+52.70%+87.94%+76.19%+134.92%

Analyst Ratings

The average analyst rating for Odyssey Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJun '26
Strong Buy4
Buy1
Hold0
Sell0
Strong Sell0
Total5

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wedbush
Wedbush
Buy
Initiates
$30
BuyInitiates$30+76.19%Jun 2, 2026
Oppenheimer
Oppenheimer
Buy
Initiates
$40
BuyInitiates$40+134.92%Jun 2, 2026
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
n/a
BuyInitiatesn/an/aJun 2, 2026
TD Cowen
TD Cowen
Buy
Initiates
$17
BuyInitiates$17-0.39%Jun 2, 2026
J.P. Morgan
J.P. Morgan
Buy
Initiates
$26
BuyInitiates$26+52.70%Jun 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 2.98M
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-3.56
EPS Next Year
-3.83
from -3.56
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-1.04M4.47M2.98M-
Revenue Growth
--331.24%-33.45%-100.00%
Operating Income
-122.54M-133.44M-135.22M-155.72M-174.75M
Net Income
-124.67M-125.94M-129.32M-148.65M-165.48M
EPS
-----3.56
Free Cash Flow
--78.21M-66.42M-85.05M-162.00M
No. Analysts
----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth202620272028
High
-100.0%
Avg
-100.0%
Low
-100.0%

EPS Forecast

EPS202620272028
High-3.23
Avg-3.56
Low-3.89

EPS Growth

EPS Growth20272028
High-
Avg-
Low-